Gilead Sciences has underperformed the broader market YTD, but Wall Street analysts are still cautiously optimistic about the stock’s prospects.
After CONMED's 33% slump this year, does its sharp rally off the April lows suggest the worst is over for this growth stock?
Despite its remarkable post-earnings rally, here's a dividend stock that still carries a bargain tag.
As artificial intelligence and robotics gear up for a monumental decade ahead, here's a healthcare equipment company on the verge of a 'tremendous growth cycle.'
Parking some of your dollars in high-performing sector ETFs may juice your portfolio's returns.
Hello fellow traders. In this technical blog we’re going to take a quick look at the Elliott Wave charts of (XLV) ETF, published in members area of the website. As our members know we have been favoring...
Top ETFs for all 11 S&P 500 sectors.
Hello everyone. In today’s article, we will look at the past performance of the 1 Hour Elliott Wave chart of Health Care Select Sector (XLV) . The rally from 1.25.2024 low at $137.21 unfolded as 5 waves...
The biotechnology sector, known for its high-risk, high-reward investment landscape, has once again proven its potential for delivering staggering returns. The recent acquisition of Ambrx Biopharma by...
In this technical blog, we will look at the past performance of the 4-hour Elliott Wave Charts of (XLV) . We presented to members at the elliottwave-forecast. In which, the rally from 27 October 2023...